Pharmaceutical applications of some spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Adsorption, diffusion, and thermodynamic properties of materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (26)
Show source-provided references
1. Alvarez, A., 1984. Sepiolite: properties and uses. In: Singer, A., Galán, E. (Eds.), Palygorskite–Sepiolite. Occurrences, Genesis and Uses. Elsevier, Amsterdam, pp. 253–287.10.1016/S0070-4571(08)70044-X ↗
2. Effect of sepiolite on pellet durability in feeds differing in fat and fibre content10.1016/0377-8401(94)00749-Y ↗
3. Ausschub für Gefahrrstoffe, 1988. Neue TRGS 517 und 552. Beschlub zur umstufung von asbest. Bun desarbeitsblatt 9: 84–86.
4. Clinical and radiological study in sepiolite workers10.1080/00039896.1980.10667517 ↗
5. BPC (British Parmacopoeia Convention), 1988a. Attapulgite. In: British Pharmacopoeia. British Parmacopoeia Convention edn., London, pp. 51–52.
6. BPC (British Parmacopoeia Convention), 1988b. Activated attapulgite. In: British Pharmacopoeia. British Parmacopoeia Convention edn., London, p. 52.
7. BPC (British Parmacopoeia Convention), 1988c. Bentonite. In: British Pharmacopoeia. British Parmacopoeia Convention edn., London, pp. 62.
8. Brittain, H.G., 1995. Ultraviolet/visible diffuse reflectance spectroscopy. In: Brittain, H.G. (Ed.), Physical Characterization of Pharmaceutical Solids. Marcel Dekker, New York, 37–58.10.1201/b14204-3 ↗
9. EPC (European Pharmacopoeia Convention), 1990. Control de la contaminación microbiana en productos no obligatoriamente estériles. Dirección General de Farmacia y Productos Sanitarios. Ministerio de Sanidad y Consumo, Madrid, V. 2.1.8.
10. Viscosity of some clay-based coating colors at high shear rates10.1007/BF01339890 ↗
11. The effect of dissolved polymers on the rheological properties of coating colours10.1007/BF01329745 ↗
12. Minerales utilizados en la industria farmacéutica
13. In vitro biological effects of clay minerals advised as substitutes for asbestos10.1007/BF00757622 ↗
14. Sepiolite, a potential excipient for drugs subject to oxidative degradation10.1002/jps.2600700219 ↗
15. Criterios morfológicos, cristalográficos y geoquı́micos de diferenciación entre sepiolitas de origen sedimentario e hidrotermal
16. Mineral quantification in sepiolite–palygorskite deposits using X-ray diffraction and chemical data10.1180/claymin.1996.031.2.07 ↗
17. A study of spanish sepiolite workers10.1136/thx.48.4.370 ↗
18. Influence of electrolytes on structure formation in palygorskite dispersions
19. Geochemistry of spanish sepiolite–palygorskite deposits: genetic considerations based on trace elements and isotopes10.1016/0009-2541(94)90026-4 ↗
20. USPC (United States Pharmacopoeial Convention), 1990a. Activated Attapulgite. In: The United States Pharmacopoeia XXII. United States Pharmacopoeial Convention, Rockville, 125.
21. USPC (United States Pharmacopoeial Convention), 1990b. Colloidal Activated Attapulgite. In: The United States Pharmacopoeia XXII. United States Pharmacopoeial Convention, Rockville, pp. 125.
22. USPC (United States Pharmacopoeial Convention), 1990c. Bentonite. In: The National Formulary XVII. United States Pharmacopoeial Convention, Rockville, pp. 1902–1903.
23. USPC (United States Pharmacopoeial Convention), 1990d. Bentonite magma. In: The National Formulary XVII. United States Pharmacopoeial Convention, Rockville, p. 1904.
24. USPC (United States Pharmacopoeial Convention), 1990e. Purified bentonite. In: The National Formulary XVII. United States Pharmacopoeial Convention, Rockville, pp. 1903–1904.
25. USPC (United States Pharmacopoeial Convention), 1990f. Magnesium aluminum silicate. In: The National Formulary XVII. United States Pharmacopoeial Convention, Rockville, pp. 1943–1944.
26. Identification des facteurs cancérogènes pour l'homme dans les Monographies du CIRC